LGND Exercise Disclosure
Reardon Andrew · SEC Form 4 · Filed Oct 6, 2026
Exercise
Calculated transaction value
$0
Reardon Andrew CLO & Secretary
LGND
Transaction date
Oct 2, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 4 days later
LGND daily price context
Close on/before transaction
$302.96
Oct 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 340 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001950232-26-000003
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1.54M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 2, 2026 | $599.8K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 2, 2026 | $123.7K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 2, 2026 | $72.19K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 2, 2026 | $467.43K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 2, 2026 | $251.99K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 2, 2026 | $5.23K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Oct 2, 2026 | $17.77K |
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Oct 2, 2026 | $0 |